Study on the Quality of Life and Pathological State in Patients Who Underwent Radical Cystectomy
Launched by IRCCS SAN RAFFAELE · Dec 6, 2023
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how the quality of life and health conditions change for patients who have had a radical cystectomy, which is a surgery to remove the bladder due to bladder cancer. The study aims to understand how this surgery affects patients' everyday lives and overall well-being. It is currently recruiting participants who are at least 18 years old and have undergone this surgery.
Eligible participants should be able to read and sign a consent form, which means they understand what the study involves. Those who join the study can expect to share their experiences and health information, helping researchers learn more about life after bladder surgery. This trial is important because it can provide valuable insights that may improve care and support for future patients undergoing similar treatments.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • subjects underwent radical cystectomy
- • \> 18 years old
- • Ability to read and sign the informed consent
- Exclusion Criteria:
- • Age \<18 years
- • Inability to read and sign the informed consent
About Irccs San Raffaele
IRCCS San Raffaele is a prestigious research hospital and clinical trial sponsor based in Milan, Italy, renowned for its commitment to advancing medical science through innovative research and high-quality patient care. As an Institute for Research and Healthcare, it specializes in a wide range of therapeutic areas, including oncology, neurology, and cardiology, and is dedicated to translating scientific discoveries into effective clinical practices. With a multidisciplinary team of experts and state-of-the-art facilities, IRCCS San Raffaele plays a pivotal role in conducting rigorous clinical trials that contribute to the development of novel treatments and improve patient outcomes globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Milan, Mi, Italy
Patients applied
Trial Officials
Francesco Montorsi, MD
Principal Investigator
IRCCS Ospedale San Raffaele
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported